Mounjaro
$1,499/month
A brand-name tirzepatide treatment designed to support advanced metabolic health and weight management.
Consultation and shipping apply separately.
What is Mounjaro?
Mounjaro (tirzepatide) is a once-weekly, injectable medication used for chronic weight management and type 2 diabetes treatment. It’s the first dual GIP and GLP-1 receptor agonist, designed to improve insulin sensitivity, regulate blood sugar, reduce appetite, and promote sustained weight loss.
Mounjaro works by mimicking two natural gut hormones—glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). These hormones help regulate insulin levels, delay gastric emptying, and reduce cravings, resulting in a multi-faceted approach to metabolic support and appetite control. The dual-action mechanism makes Mounjaro more effective for many patients than GLP-1 therapies alone.
Initially developed for type 2 diabetes, Mounjaro has gained widespread clinical use for weight loss in non-diabetic individuals, especially those with obesity, insulin resistance, or metabolic syndrome. It’s FDA-approved for both indications and is commonly prescribed as part of a provider-managed weight loss program.
Administered via a simple, once-weekly subcutaneous injection, Mounjaro is a powerful tool for individuals looking to improve blood sugar control and achieve meaningful, sustainable weight loss—with provider oversight and long-term health in mind.
Start Your Mounjaro Journey in 3 Simple Steps
1
Create Your Account – Begin Your Weight Loss Plan
Sign up quickly and securely to access Mounjaro therapy—a provider-approved, clinically guided treatment tailored to your metabolic and weight loss goals.
2
Online Consultation – Personalized Treatment Just for You
Complete a brief intake and connect with a licensed provider who will assess your medical history and lifestyle. You’ll receive a customized Mounjaro prescription and dosage schedule that fits your unique needs.
3
Delivered to Your Door – Progress Starts at Home
Once prescribed, your Mounjaro injections are shipped discreetly to your home. Administer once weekly as directed to support appetite regulation, blood sugar control, and long-term weight management.
Expert-Backed Options for Sustainable Weight Loss
Frequently Asked Questions
Get answers to common questions about Mounjaro—how it works, what results to expect, and how to get started with dual-action GLP-1 and GIP therapy.
Want to explore more questions? Read our full FAQ here
Mounjaro (tirzepatide) is a dual-acting GLP-1 and GIP receptor agonist. It helps regulate blood sugar, slows digestion, suppresses appetite, and promotes weight loss by targeting two key incretin pathways instead of just one.
While both are GLP-1 receptor agonists, Mounjaro also activates the GIP receptor. This dual action may offer greater weight loss and blood sugar control benefits compared to GLP-1 medications alone.
Mounjaro is given as a once-weekly subcutaneous injection. Your provider will determine the right dosage and show you how to administer it at home.
Patients often notice reduced appetite within the first few weeks. More significant weight reduction and metabolic improvements are typically seen after 8–12 weeks of consistent use, especially when combined with diet and exercise.
Common side effects include nausea, constipation, diarrhea, and decreased appetite. These are generally mild and improve over time. Rare but serious risks include pancreatitis and gallbladder issues.
Ready to Take the Next Step?
Start your treatment with Mounjaro—clinically proven, provider-guided, and designed to deliver powerful dual-action support for blood sugar control and weight loss.
Disclaimer: Mounjaro (tirzepatide) is FDA-approved for the treatment of type 2 diabetes and is being used off-label for weight management. This product is prescribed only when a licensed healthcare provider determines it is medically appropriate following a thorough consultation. Individual results may vary.